Wendan Yu

2.2k total citations
50 papers, 1.5k citations indexed

About

Wendan Yu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Wendan Yu has authored 50 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Molecular Biology, 15 papers in Cancer Research and 11 papers in Oncology. Recurrent topics in Wendan Yu's work include RNA modifications and cancer (8 papers), Estrogen and related hormone effects (7 papers) and Genomics and Chromatin Dynamics (6 papers). Wendan Yu is often cited by papers focused on RNA modifications and cancer (8 papers), Estrogen and related hormone effects (7 papers) and Genomics and Chromatin Dynamics (6 papers). Wendan Yu collaborates with scholars based in China, United States and Switzerland. Wendan Yu's co-authors include Wuguo Deng, Wei Guo, Wenlin Huang, Xiangsheng Xiao, Wangbing Chen, Shilei Zhao, Ranran Tang, Zhenglin Li, Sheng Hu and Jingshu Wang and has published in prestigious journals such as PLoS ONE, Free Radical Biology and Medicine and PLoS Biology.

In The Last Decade

Wendan Yu

48 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wendan Yu China 25 940 336 315 163 141 50 1.5k
Wei‐En Yang Taiwan 16 713 0.8× 268 0.8× 391 1.2× 166 1.0× 118 0.8× 32 1.3k
Michael Witcher Canada 21 1.3k 1.4× 267 0.8× 165 0.5× 123 0.8× 110 0.8× 37 1.6k
Qiao Zheng China 23 809 0.9× 422 1.3× 244 0.8× 74 0.5× 121 0.9× 62 1.6k
Miyong Yun South Korea 22 1.1k 1.1× 300 0.9× 370 1.2× 56 0.3× 207 1.5× 53 1.5k
Nasser Samadi Iran 22 794 0.8× 249 0.7× 342 1.1× 69 0.4× 114 0.8× 31 1.2k
Andrés García‐Palomo Spain 13 553 0.6× 213 0.6× 341 1.1× 223 1.4× 61 0.4× 36 1.1k
Daniele Avanzato Italy 15 996 1.1× 465 1.4× 338 1.1× 54 0.3× 160 1.1× 18 1.8k
Wei Han China 24 928 1.0× 208 0.6× 504 1.6× 45 0.3× 143 1.0× 80 1.5k
Silvia Cristofanon Germany 23 1.1k 1.2× 250 0.7× 227 0.7× 124 0.8× 240 1.7× 31 1.6k

Countries citing papers authored by Wendan Yu

Since Specialization
Citations

This map shows the geographic impact of Wendan Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wendan Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wendan Yu more than expected).

Fields of papers citing papers by Wendan Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wendan Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wendan Yu. The network helps show where Wendan Yu may publish in the future.

Co-authorship network of co-authors of Wendan Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Wendan Yu. A scholar is included among the top collaborators of Wendan Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wendan Yu. Wendan Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Ruonan, Feng Zhang, Jiazhi Li, et al.. (2025). GATA2 promotes cervical cancer progression under the transcriptional activation of TRIP4. Cellular Signalling. 132. 111778–111778.
2.
Yu, Wendan, Shilong Han, Sheng Hu, et al.. (2024). KIF15 promotes human glioblastoma progression under the synergistic transactivation of REST and P300. International Journal of Biological Sciences. 20(13). 5127–5144. 4 indexed citations
3.
Hao, Jiaojiao, Jinsheng Huang, Yan Zuo, et al.. (2023). A novel TOX3-WDR5-ABCG2 signaling axis regulates the progression of colorectal cancer by accelerating stem-like traits and chemoresistance. PLoS Biology. 21(9). e3002256–e3002256. 7 indexed citations
4.
Li, Wenyang, Sheng Hu, Chunfang Tian, et al.. (2021). TRIP4 transcriptionally activates DDIT4 and subsequent mTOR signaling to promote glioma progression. Free Radical Biology and Medicine. 177. 31–47. 7 indexed citations
5.
Liu, Kai‐Li, Yue Yan, Kun Zou, et al.. (2020). Melatonin increases the chemosensitivity of diffuse large B-cell lymphoma cells to epirubicin by inhibiting P-glycoprotein expression via the NF-κB pathway. Translational Oncology. 14(1). 100876–100876. 19 indexed citations
6.
Hao, Jiaojiao, Hua Xu, Meihua Luo, et al.. (2017). The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy. Journal of Investigative Dermatology. 138(1). 159–170. 10 indexed citations
7.
Zhang, Zhifeng, Fufu Zheng, Zhenlong Yu, et al.. (2017). XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers. PLoS ONE. 12(10). e0186900–e0186900. 27 indexed citations
8.
Xu, Feng, Xiangdong Xu, Xiangsheng Xiao, et al.. (2017). NMI inhibits cancer stem cell traits by downregulating hTERT in breast cancer. Cell Death and Disease. 8(5). e2783–e2783. 22 indexed citations
9.
Yu, Wendan, Li Li, Fufu Zheng, et al.. (2017). β-Catenin Cooperates with CREB Binding Protein to Promote the Growth of Tumor Cells. Cellular Physiology and Biochemistry. 44(2). 467–478. 19 indexed citations
10.
Tang, Ranran, Xiangdong Xu, Wenjing Yang, et al.. (2016). MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways. Cancer Letters. 373(1). 77–87. 28 indexed citations
11.
Zhang, Ningning, Yunpeng Xie, Yingying Gao, et al.. (2016). Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4. Cellular Physiology and Biochemistry. 40(6). 1559–1569. 29 indexed citations
12.
Yang, Xuan, Jingshu Wang, Zhenglin Li, et al.. (2015). hnRNPA2/B1 activates cyclooxygenase‐2 and promotes tumor growth in human lung cancers. Molecular Oncology. 10(4). 610–624. 36 indexed citations
13.
Tang, Zhipeng, Wendan Yu, Changlin Zhang, et al.. (2015). CREB‐binding protein regulates lung cancer growth by targeting MAPK and CPSF4 signaling pathway. Molecular Oncology. 10(2). 317–329. 35 indexed citations
14.
Zhang, Yong, Zhenlong Yu, Yao Xiao, et al.. (2014). Melatonin Enhances the Anti-Tumor Effect of Fisetin by Inhibiting COX-2/iNOS and NF-κB/p300 Signaling Pathways. PLoS ONE. 9(7). e99943–e99943. 64 indexed citations
15.
Chen, Wangbing, Lijun Qin, Shusen Wang, et al.. (2014). CPSF4 activates telomerase reverse transcriptase and predicts poor prognosis in human lung adenocarcinomas. Molecular Oncology. 8(3). 704–716. 24 indexed citations
16.
Yu, Zhenlong, Wei Guo, Xiaochi Ma, et al.. (2014). Gamabufotalin, a bufadienolide compound from toad venom, suppresses COX-2 expression through targeting IKKβ/NF-κB signaling pathway in lung cancer cells. Molecular Cancer. 13(1). 203–203. 69 indexed citations
17.
Guo, Wei, Wangbing Chen, Wendan Yu, Wenlin Huang, & Wuguo Deng. (2013). Small interfering RNA-based molecular therapy of cancers. Chinese Journal of Cancer. 32(9). 488–493. 59 indexed citations
18.
Liu, Liqun, Wei Guo, Wendan Yu, & Zeshan You. (2013). Fisetin Simultaneously Targets Apaf-1, ERK, and COX-2 Signaling Leading to Growth Inhibition and Apoptosis in Human Cervical Carcinoma Cell In Vitro. Journal of Sun Yat-sen University. 34(1). 75. 1 indexed citations
19.
Kang, Jian, Liming Xu, Wendan Yu, et al.. (2013). Effect of Phosphoglucosamine Mutase on Biofilm Formation and Antimicrobial Susceptibilities in M. smegmatis glmM Gene Knockdown Strain. PLoS ONE. 8(4). e61589–e61589. 19 indexed citations
20.
Wang, Jingshu, Wei Guo, Wangbing Chen, et al.. (2012). Expression of Concern: Melatonin potentiates the antiproliferative and pro‐apoptotic effects of ursolic acid in colon cancer cells by modulating multiple signaling pathways. Journal of Pineal Research. 54(4). 406–416. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei‐En Yang Breakdown of academic impact, for papers by Michael Witcher Breakdown of academic impact, for papers by Qiao Zheng Breakdown of academic impact, for papers by Miyong Yun Breakdown of academic impact, for papers by Nasser Samadi Breakdown of academic impact, for papers by Andrés García‐Palomo Breakdown of academic impact, for papers by Daniele Avanzato Breakdown of academic impact, for papers by Wei Han Breakdown of academic impact, for papers by Silvia Cristofanon
Rankless by CCL
2026